112 related articles for article (PubMed ID: 1213132)
1. [Influence of low doses of a heparin-urea complex on the aggregation of thrombocytes and the fibrinolytic activity of blood in intravenous infusion and in in vitro experiments].
Kudriashov BA; Patorova VE; Liapina LA
Farmakol Toksikol; 1975; 38(4):441-4. PubMed ID: 1213132
[TBL] [Abstract][Full Text] [Related]
2. [Effect of heparin on the aggregation function of thrombocytes].
Zhukovskaia ES; Blindar' VN
Farmakol Toksikol; 1984; 47(5):36-40. PubMed ID: 6500033
[TBL] [Abstract][Full Text] [Related]
3. [Fibrinolysis in the blood of animals exposed to the chronic per os use of a heparin-urea complex].
Kudriashov BA; Liapina LA
Farmakol Toksikol; 1977; 40(5):559-63. PubMed ID: 923778
[TBL] [Abstract][Full Text] [Related]
4. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].
Nimmerfall K; Mischke R
Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154
[TBL] [Abstract][Full Text] [Related]
5. [Action of heparin, adrenaline and an adrenaline-heparin complex on thrombocyte aggregation and on plasma lytic activity in animals].
Kudriashov BA; Pastorova VE; Liapina LA
Probl Gematol Pereliv Krovi; 1973 May; 18(5):28-33. PubMed ID: 4781491
[No Abstract] [Full Text] [Related]
6. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
Kudrjashov BA; Pastorova VE; Lyapina LA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
[TBL] [Abstract][Full Text] [Related]
7. [The blood anticoagulant system in rats perorally administered a heparin-acetylsalicylic acid complex].
Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
Izv Akad Nauk SSSR Biol; 1991; (4):625-30. PubMed ID: 1787232
[TBL] [Abstract][Full Text] [Related]
8. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
[TBL] [Abstract][Full Text] [Related]
9. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
Gallistl S; Muntean W; Leis HJ
Thromb Haemost; 1995 Oct; 74(4):1163-8. PubMed ID: 8560429
[TBL] [Abstract][Full Text] [Related]
10. [Importance of thrombocyte aggregation in altering the fibrinolytic activity and nonenzymatic fibrinolysis of the blood plasma].
Pastorova VE; Bazaz'ian GG; Romanovskiĭ AA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (8):58-61. PubMed ID: 6215958
[No Abstract] [Full Text] [Related]
11. [Effect of heparin on platelet aggregation in vitro].
Róka L; Isert D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
[TBL] [Abstract][Full Text] [Related]
12. [Effect of complexes of heparin with plasma proteins on the anticoagulant and fibrinolytic activity of blood].
Kudriashov BA; Pastorova VE; Liapina LA
Fiziol Zh SSSR Im I M Sechenova; 1986 Dec; 72(12):1653-8. PubMed ID: 3817209
[TBL] [Abstract][Full Text] [Related]
13. [Effect of Complamin on fibrinolysis and platelet aggregation in the aged].
Matijević N; Sisić I; Korolija P; Pendić B
Bilt Hematol Transfuz; 1980; 8(1):37-43. PubMed ID: 7337681
[TBL] [Abstract][Full Text] [Related]
14. Patho-physiological studies on lactic acid-induced pulmonary thrombosis in rat. I. Effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid.
Tomikawa M
Thromb Diath Haemorrh; 1975 Sep; 34(1):145-58. PubMed ID: 1188708
[TBL] [Abstract][Full Text] [Related]
15. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
Pastorova VE
Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
[TBL] [Abstract][Full Text] [Related]
16. [Heparin increases platelet aggregation and inhibits fibrinolysis, especially in primary hypertriglyceridemia and after myocardial infarction].
Jastrzebska M; Chełstowski K; Torbus-Lisiecka B; Pieczul-Mróz J; Wesołowska T; Wira D
Kardiol Pol; 1992 Sep; 37(9):136-41. PubMed ID: 1479769
[TBL] [Abstract][Full Text] [Related]
17. Effect of heparin and heparinoids on platelet aggregation.
Cepelák V; Roubal Z; Zemanová I; Opatrný K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
[TBL] [Abstract][Full Text] [Related]
18. [Anticoagulant and nonenzymatic fibrinolytic activity of plasma in animals after intravenous injection of a heparin-antithrombin III complex].
Kudriashov BA; Pastorova VE; Liapina LA
Biull Eksp Biol Med; 1985 Jan; 99(1):62-4. PubMed ID: 3967074
[TBL] [Abstract][Full Text] [Related]
19. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
[TBL] [Abstract][Full Text] [Related]
20. [Study of the induction of thrombocyte adhesiveness in the presence of heparin].
Kharlitskaia EV; Zolotukhin SI
Farmakol Toksikol; 1976; 39(4):440-4. PubMed ID: 17546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
